Clinical Trial Update: Nicotinic Receptor Genetic Variation and Alcohol Reward [Phase 1]

View source ↗

Summary

Phase 1 clinical trial sponsored by NIAAA investigating how nicotinic receptor genetic variation influences alcohol reward; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Drinking | Phase 1 | Status: RECRUITING